Jun 17, 2026 04:19AM
May 12, 2026 07:00AM
May 5, 2026 04:21AM
May 4, 2026 04:30PM
May 4, 2026 04:30PM
May 4, 2026 10:14AM
Apr 10, 2026 06:59AM Opus Genetics Announces Data Presentations at the 2026 American Society of Cataract and Refractive Surgery Annual Meeting
Mar 10, 2026 07:00AM
Feb 25, 2026 06:59AM
Feb 25, 2026 06:59AM
Jan 20, 2026 05:06AM
Jan 8, 2026 07:07AM
Jan 8, 2026 07:00AM
Nov 12, 2025 07:00AM Opus Genetics Announces Financial Results for Third Quarter 2025 and Provides Corporate Update
Nov 6, 2025 07:03AM
Nov 6, 2025 07:01AM
Nov 6, 2025 07:00AM
Nov 6, 2025 07:00AM
Oct 1, 2025 06:55AM
Sep 30, 2025 07:00AM
Sep 30, 2025 07:00AM Opus Genetics Reports Positive Pediatric Data from OPGx-LCA5 Phase 1/2 Trial in Leber Congenital Amaurosis Type 5 (LCA5)
Sep 4, 2025 08:00AM
Sep 4, 2025 08:00AM
Aug 18, 2025 08:01AM
Aug 18, 2025 08:00AM
Aug 13, 2025 04:30PM
Aug 5, 2025 08:00AM
Jul 23, 2025 08:00AM Opus Genetics and the Global RDH12 Alliance Partner to Advance RDH12 Gene Therapy for Inherited Childhood Blindness
Jul 3, 2025 04:30PM
Jun 26, 2025 06:56AM
Jun 26, 2025 06:55AM
Jun 23, 2025 08:00AM
Jun 2, 2025 08:00AM
Jun 2, 2025 08:00AM
May 15, 2025 08:00AM Opus Genetics Announces Financial Results for First Quarter 2025 and Provides Corporate Update
May 12, 2025 08:00AM
May 6, 2025 08:03AM
May 6, 2025 08:00AM
May 5, 2025 08:00AM
Apr 15, 2025 10:36AM
Apr 8, 2025 08:01AM
Apr 8, 2025 08:00AM Opus Genetics Announces One-Month Clinical Data from Pediatric Patient in Phase 1/2 Trial of OPGx-LCA5 Gene Therapy in Inherited Retinal Diseases
Apr 2, 2025 08:00AM
Apr 1, 2025 06:51AM
Mar 31, 2025 08:20AM
Mar 21, 2025 05:03PM
Mar 21, 2025 09:30AM
Mar 21, 2025 09:12AM
Mar 21, 2025 09:11AM Opus Genetics Announces Pricing of Public Offering and Concurrent Private Placement with Proceeds of Over $20 Million
Mar 19, 2025 03:57PM

323,398 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All